Autoimmune pancreatitis and immunoglobulin G4-related disease (IgG4-RD) are new disease entities characterized by enhanced IgG4 antibody responses. Serum IgG4 antibody concentrations are widely used as useful biomarkers for the diagnosis and monitoring of disease activity in autoimmune pancreatitis and IgG4-RD.